<DOC>
	<DOCNO>NCT02671162</DOCNO>
	<brief_summary>The purpose study determine whether Fumaria Parviflora L. minimize severity pruritus patient end-stage renal disease .</brief_summary>
	<brief_title>Evaluating Effect Fumaria Parviflora L. Uremic Pruritus</brief_title>
	<detailed_description>Uremic Pruritus still common complication end-stage renal disease patient . The pathogenesis Uremic Pruritus unknown , therefore treatment ineffective . According several study Uremic Pruritus isolate skin disease . It seem systemic inflammatory disease derange balance T helper cell differentiation . In study investigator consider evaluate effect Fumaria Parviflora L. uremic pruritus double blind placebo control clinical trial . It hypothesize oral Fumaria Parviflora L. may minimize uremic pruritus decrease serum Interferon gamma ( IFN-Î³ ) high-sensitive C reactive protein ( hs-CRP ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<criteria>Hemodialysis patient Suffering pruritus least 6 week Have respond drug visual analogue scale ( VAS ) equal 4 Liver disease Respiratory disease Dermatological disease Hemoglobin le 10 Cholestasis Malignancies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Pruritus</keyword>
	<keyword>End-Stage Renal Disease</keyword>
</DOC>